Thermo Fisher Scientific logo

Thermo Fisher Scientific

North America, Massachusetts, United States, Waltham

Description

Thermo Fisher Scientific is a biotechnology and laboratory equipment company that provides a wide range of scientific products and services.

Investor Profile

Thermo Fisher Scientific has made 4 investments, with 2 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Corporate Round (25%)
  • Series D (25%)

Country Focus

  • China (25%)
  • Israel (25%)
  • United States (25%)
  • Belgium (25%)

Industry Focus

  • Health Diagnostics
  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Thermo Fisher Scientific frequently co-invest with?

PA
Europe, Hallands Lan, Sweden, Halmstad
Co-Investments: 1
Sunland Capital
North America, Texas, United States, Houston
Co-Investments: 1
Pfizer
North America, New York, United States, New York
Co-Investments: 1
A
Europe, Oost-Vlaanderen, Belgium, Merelbeke
Co-Investments: 1
OurCrowd
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
Shiyu Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
YF Capital
Asia, Shanghai, China, Jingan
Co-Investments: 1
NVIDIA
North America, California, United States, Santa Clara
Co-Investments: 1
CT
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by Thermo Fisher Scientific?

miDiagnostics

Leuven, Vlaams-Brabant, Belgium

miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.

Health Diagnostics
Series DDec 4, 2024
Amount Raised: $31,536,788
CytoReason

Tel Aviv, Tel Aviv, Israel

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series BJul 17, 2024
Amount Raised: $80,000,000
Ionpath

Menlo Park, California, United States

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

BiotechnologyHealth CareHealth DiagnosticsMedical
Corporate RoundMay 11, 2022
WuXi Diagnostics

Shanghai, Shanghai, China

WuXi Diagnostics is the first enabling platform company in China to practice integrated diagnosis.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series BFeb 23, 2021
Amount Raised: $150,000,000